Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer.
Andres S, Finch L, Iasonos A, Zhou Q, Girshman J, Chhetri-Long R, Green H, Jang D, O'Cearbhaill R, Kyi C, Cohen S, Friedman C, Makker V, Chi DS, Sonoda Y, Chiang S, Aghajanian C, Weigelt B, Grisham RN.
Andres S, et al. Among authors: finch l.
Gynecol Oncol. 2024 Oct;189:30-36. doi: 10.1016/j.ygyno.2024.06.026. Epub 2024 Jul 10.
Gynecol Oncol. 2024.
PMID: 38991472
Clinical Trial.